GJC2 and Pelizaeus-Merzbacher-like disease: Compared with “classical” Pelizaeus–Merzbacher Disease (PMD) with PLP1 mutations, HLD2/PMLD patients with GJC2 mutations initially have a milder phenotype, with higher achieved cognitive levels and speech capacity.